Publications by authors named "Thomas Buchner"

Claim this Profile
B
Blurring the lines between printed machines and living robots.
Robert K Katzschmann, Thomas J K Buchner

Sci Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrohydraulic musculoskeletal robotic leg for agile, adaptive, yet energy-efficient locomotion.
Thomas J K Buchner, Toshihiko Fukushima, Amirhossein Kazemipour, Stephan-Daniel Gravert, Manon Prairie

Nat Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-voltage electrohydraulic actuators for untethered robotics.
Stephan-Daniel Gravert, Elia Varini, Amirhossein Kazemipour, Mike Y Michelis, Thomas Buchner

Sci Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vision-controlled jetting for composite systems and robots.
Thomas J K Buchner, Simon Rogler, Stefan Weirich, Yannick Armati, Barnabas Gavin Cangan

Nature· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microfluidic Tissue Engineering and Bio-Actuation.
Miriam Filippi, Thomas Buchner, Oncay Yasa, Stefan Weirich, Robert K Katzschmann

Adv Mater· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaling Up Soft Robotics: A Meter-Scale, Modular, and Reconfigurable Soft Robotic System.
Shuguang Li, Samer A Awale, Katharine E Bacher, Thomas J Buchner, Cosimo Della Santina

Soft Robot· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sub-cycle atomic-scale forces coherently control a single-molecule switch.
Dominik Peller, Lukas Z Kastner, Thomas Buchner, Carmen Roelcke, Florian Albrecht

Nature· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
Eva Lengfelder, Dennis Görlich, Daniel Nowak, Karsten Spiekermann, Claudia Haferlach

Eur J Haematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.
Michele Pohlen, Nils H Thoennissen, Jan Braess, Johannes Thudium, Christoph Schmid

PLoS One· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy of older persons with acute myeloid leukaemia.
Utz Krug, Robert Peter Gale, Wolfgang E Berdel, Carsten Müller-Tidow, Matthias Stelljes

Leuk Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.
Michele Pohlen, Nils H Thoennissen, Jan Braess, Johannes Thudium, Christoph Schmid

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.
Tobias Herold, Klaus H Metzeler, Sebastian Vosberg, Luise Hartmann, Vindi Jurinovic

Genes Chromosomes Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R Appelbaum

Blood· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 17-gene stemness score for rapid determination of risk in acute leukaemia.
Stanley W K Ng, Amanda Mitchell, James A Kennedy, Weihsu C Chen, Jessica McLeod

Nature· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.
Michele Pohlen, Julia Marx, Alexander Mellmann, Karsten Becker, Rolf M Mesters

Haematologica· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.
Klaus H Metzeler, Tobias Herold, Maja Rothenberg-Thurley, Susanne Amler, Maria C Sauerland

Blood· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.
Luise Hartmann, Sayantanee Dutta, Sabrina Opatz, Sebastian Vosberg, Katrin Reiter

Nat Commun· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic importance of expression of the Wilms' tumor 1 gene in newly diagnosed acute promyelocytic leukemia.
Anna Hecht, Florian Nolte, Daniel Nowak, Verena Nowak, Mark Reinwald

Leuk Lymphoma· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias].
Ute Kossak-Roth, Susanne Saußele, Carlo Aul, Thomas Büchner, Hartmut Döhner

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia.
Mirle Schemionek, Behzad Kharabi Masouleh, Yvonne Klaile, Utz Krug, Katja Hebestreit

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 4-gene expression score associated with high levels of Wilms Tumor-1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia.
Ahmadreza Niavarani, Tobias Herold, Yasmin Reyal, Maria C Sauerland, Thomas Buchner

Br J Haematol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML.
Felix S Lichtenegger, Isabell Kondla, Michael Krempasky, Anna L Weber, Tobias Herold

Cancer Immunol Immunother· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia.
Anna Hecht, Daniel Nowak, Verena Nowak, Benjamin Hanfstein, Thomas Büchner

Leuk Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing life satisfaction in acute myeloid leukemia survivors following allogeneic stem cell transplantation: a cross-sectional study.
Susanne Amler, Maria Cristina Sauerland, Christian Deiters, Thomas Büchner, Andrea Schumacher

Health Qual Life Outcomes· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis.
Tobias Herold, Klaus H Metzeler, Sebastian Vosberg, Luise Hartmann, Christoph Röllig

Blood· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis